Detalhe da pesquisa
1.
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.
Cell
; 173(2): 470-484.e18, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551267
2.
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer.
Mol Cell
; 81(10): 2094-2111.e9, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878293
3.
Signalling input from divergent pathways subverts B cell transformation.
Nature
; 583(7818): 845-851, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699415
4.
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.
Nature
; 588(7838): 491-497, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33149299
5.
PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis.
Proc Natl Acad Sci U S A
; 118(7)2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531346
6.
Author Correction: IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.
Nature
; 592(7852): E3, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712811
7.
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
Br J Cancer
; 118(7): 1000-1004, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531323
8.
The GM-CSF receptor utilizes ß-catenin and Tcf4 to specify macrophage lineage differentiation.
Differentiation
; 83(1): 47-59, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22099176
9.
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.
Haematologica
; 102(12): e490-e493, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935844
10.
JAFFAL: detecting fusion genes with long-read transcriptome sequencing.
Genome Biol
; 23(1): 10, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991664
11.
SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia.
Blood Adv
; 6(7): 2373-2387, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35061886
12.
Metabolic Gatekeepers of Pathological B Cell Activation.
Annu Rev Pathol
; 16: 323-349, 2021 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33321055
13.
MEF2D Fusions Drive Oncogenic Pre-BCR Signaling in B-ALL.
Blood Cancer Discov
; 1(1): 18-20, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661138
14.
A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.
Hemasphere
; 8(2): e1, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38435422
15.
TALLSorts: a T-cell acute lymphoblastic leukemia subtype classifier using RNA-seq expression data.
Blood Adv
; 7(24): 7402-7406, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903323
16.
Unusual PDGFRB fusion reveals novel mechanism of kinase activation in Ph-like B-ALL.
Leukemia
; 37(4): 905-909, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810896
17.
miR-155 as a potential target of IL-3 signaling in primary AML cells.
Leuk Res
; 57: 57-59, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301819
18.
A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.
Cancer Genet
; 216-217: 86-90, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025600
19.
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.
Cancer Lett
; 408: 92-101, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28866095
20.
Interleukin-3-mediated regulation of ß-catenin in myeloid transformation and acute myeloid leukemia.
J Leukoc Biol
; 96(1): 83-91, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24598054